Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.33 - $0.65 $4,189 - $8,252
-12,696 Reduced 23.07%
42,347 $20,000
Q2 2023

Aug 11, 2023

SELL
$0.2 - $0.35 $640 - $1,121
-3,204 Reduced 5.5%
55,043 $19,000
Q1 2023

May 16, 2023

BUY
$0.19 - $0.64 $11,066 - $37,278
58,247 New
58,247 $12,000
Q2 2022

Aug 15, 2022

SELL
$0.36 - $1.78 $6,973 - $34,478
-19,370 Reduced 43.3%
25,367 $45,000
Q1 2022

May 16, 2022

BUY
$0.51 - $1.0 $1,942 - $3,809
3,809 Added 9.31%
44,737 $30,000
Q4 2021

Feb 14, 2022

SELL
$0.91 - $4.16 $13,004 - $59,450
-14,291 Reduced 25.88%
40,928 $38,000
Q2 2021

Aug 11, 2021

BUY
$4.1 - $5.33 $82,770 - $107,602
20,188 Added 57.63%
55,219 $239,000
Q1 2021

May 17, 2021

BUY
$4.93 - $7.15 $112,689 - $163,434
22,858 Added 187.78%
35,031 $177,000
Q4 2020

Feb 16, 2021

SELL
$4.55 - $7.29 $157,775 - $252,788
-34,676 Reduced 74.02%
12,173 $77,000
Q2 2020

Aug 14, 2020

BUY
$3.76 - $8.01 $73,553 - $156,691
19,562 Added 71.69%
46,849 $275,000
Q1 2020

May 15, 2020

SELL
$3.5 - $8.51 $65,866 - $160,149
-18,819 Reduced 40.82%
27,287 $119,000
Q4 2019

Feb 14, 2020

BUY
$4.52 - $7.91 $85,559 - $149,728
18,929 Added 69.65%
46,106 $314,000
Q3 2019

Nov 14, 2019

SELL
$4.91 - $9.31 $242,647 - $460,090
-49,419 Reduced 64.52%
27,177 $133,000
Q2 2019

Aug 16, 2019

BUY
$7.08 - $10.6 $2,796 - $4,187
395 Added 0.52%
76,596 $565,000
Q2 2019

Aug 14, 2019

BUY
$7.08 - $10.6 $428,899 - $642,137
60,579 Added 387.78%
76,201 $562,000
Q4 2018

Feb 14, 2019

SELL
$6.59 - $11.28 $702,454 - $1.2 Million
-106,594 Reduced 87.22%
15,622 $123,000
Q3 2018

Nov 14, 2018

BUY
$9.35 - $12.44 $87,656 - $116,625
9,375 Added 8.31%
122,216 $1.32 Million
Q2 2018

Aug 14, 2018

BUY
$9.11 - $28.88 $194,589 - $616,876
21,360 Added 23.35%
112,841 $1.32 Million
Q1 2018

May 15, 2018

BUY
$14.18 - $35.6 $1.3 Million - $3.26 Million
91,481 New
91,481 $2.36 Million

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.